DuPont Nutrition & Health (N&H) has received approval from the European Commission (EC) to divest its heritage DuPont N&H Alginates business to JRS Group, a manufacturer of functional additives from plant-based raw materials. The divestiture is expected to close in Q3 2018.

The transaction with JRS Group includes the heritage DuPont N&H Alginates business, comprising pure and buffered alginates, a specific portfolio of pectin-alginate blends, the associated Landerneau production site and customer relationships.

The divestiture was a requirement set out by the EC upon its conditional approval of DuPont’s acquisition of FMC’s Health & Nutrition (H&N) business in 2017.

“The receipt of regulatory approval to divest the heritage DuPont N&H Alginates business is an important step in finalizing our integration of FMC’s Health & Nutrition Business. Our team is dedicated to creating value for our customers through the integration of our new DuPont N&H product portfolio, which combines the heritage portfolios of DuPont N&H, FMC H&N and Dow Food & Pharma to deliver a unique offering in the food ingredients and pharma excipients market,” says DuPont N&H Business President Matthias Heinzel.

In a statement, Andreas Nagel, Innovation Manager at JRS Group, said, "Receiving approval from the US Commission to acquire DuPont's Algin business is another milestone in strengthening the JRS Group Life Science Division. product portfolio to develop innovative solutions for our global customers JRS focuses on 'Green Products' made from renewable botanical resources, so alginates fit perfectly into our portfolio of excipients and hydrocolloids for pharmaceutical, food and personal care applications committed to ensuring the smooth transition of the business and will be in touch with all customers before closing. "

DuPont N&H will continue to be active in the alginates market after the transaction closes through the FMC H&N alginates portfolio. DuPont N&H is one of the world’s leading specialty ingredients companies delivering unmatched value to the food, beverage, pharmaceutical and dietary supplements industries.